Published in Transplant Proc on August 01, 2000
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol (1996) 5.38
Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol (2001) 4.98
Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol (1983) 3.32
The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science (1994) 2.53
Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol (1976) 2.36
Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. J Immunol (1974) 2.23
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol (1999) 2.05
A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today (1993) 2.02
Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol (1990) 1.67
CD40 ligand has potent antiviral activity. Nat Med (1995) 1.64
Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med (1990) 1.56
Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol (1990) 1.52
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol (1996) 1.52
Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia (2008) 1.41
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus. J Virol (2004) 1.39
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33
Lysis of herpesvirus-infected cells by immune spleen cells. Infect Immun (1975) 1.32
Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci U S A (1991) 1.22
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med (1984) 1.20
Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. J Immunol (1991) 1.16
Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol Reprod (1998) 1.12
Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J Virol (1994) 1.12
DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol Cell Biol (1997) 1.11
Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int J Cancer (1987) 1.11
Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol (1995) 1.03
Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Cancer Res (1988) 1.03
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunol Rev (1999) 1.02
Enhanced cellular immunity in macaques following a novel peptide immunotherapy. J Virol (2005) 1.02
Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology (1996) 1.01
Recombinant viruses as vaccines and immunological tools. Curr Opin Immunol (1997) 1.00
Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice. Eur J Immunol (1977) 1.00
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes. J Virol (1999) 0.92
A requirement for helper T cells in the induction of delayed-type hypersensitivity. J Immunol (1983) 0.90
IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study. J Immunol (1994) 0.90
A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo. Scand J Immunol (2004) 0.90
Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res (1992) 0.90
Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation. Matrix Biol (2013) 0.89
T-cell mediated immunity towards antigen(s) on isologous erythrocytes. Nature (1977) 0.88
A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J Virol (1996) 0.88
Growth of the IB-RS-2 pig kidney cell line in suspension culture and its susceptibility to foot-and-mouth disease virus. Appl Microbiol (1971) 0.87
Lectin-binding characteristics of related high- and low-metastatic rat mammary adenocarcinoma cell lines. Invasion Metastasis (1987) 0.86
Cytokines in innate and adaptive immunity. Rev Immunogenet (2000) 0.86
IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE). Scand J Immunol (2002) 0.86
The in vitro induction of T cells which mediate delayed-type hypersensitivity toward horse red blood cells. Cell Immunol (1979) 0.85
Isolation of gene associated with high metastatic potential in rat mammary adenocarcinomas. J Natl Cancer Inst (1990) 0.85
Involvement of plasminogen activator production with tumor metastasis in a rat model. Cancer Res (1984) 0.85
Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors. Reprod Fertil Dev (1994) 0.84
Surface properties of cells involved in antibody-dependent cytotoxicity. Cell Immunol (1976) 0.83
A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic. Int J Cancer (1982) 0.83
The use of cell fusion to analyse factors involved in tumour cell metastasis. Int J Cancer (1983) 0.83
Recombinant vaccine vector-induced protection of athymic, nude mice from influenza A virus infection. Analysis of protective mechanisms. Scand J Immunol (1992) 0.82
Streptozotocin is not toxic to the human fetal B cell. Diabetologia (1989) 0.82
A comparative study of transplant sites for endocrine tissue transplantation in the pig. Aust J Exp Biol Med Sci (1986) 0.82
Sporobolomyces: a possible cause of extrinsic allergic alveolitis. J Allergy Clin Immunol (1983) 0.82
Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells. Invasion Metastasis (1984) 0.82
DNA immunization. Immunol Cell Biol (1997) 0.82
Effect of an iron-chelating agent on lymphocyte proliferation. Aust J Exp Biol Med Sci (1984) 0.81
Technique of venous catheterization for sequential blood sampling from the pig. J Invest Surg (1991) 0.81
The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor. Cytokine (1995) 0.81
Pancreatic islet basement membrane loss and remodeling after mouse islet isolation and transplantation: impact for allograft rejection. Cell Transplant (2012) 0.81
Murine chemokine gene expression in rejecting pig proislet xenografts. Transplant Proc (2000) 0.81
Rejection of allogeneic tumor cells growing in mouse cerebrospinal fluid. Functional analysis of the inflammatory process. J Neuroimmunol (1981) 0.80
Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma. J Med Primatol (2000) 0.80
Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation. Viral Immunol (1998) 0.79
Immunology cross-reactivity between spinal cord protein and myelin basic protein. Int Arch Allergy Appl Immunol (1982) 0.79
A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques. Vaccine (2000) 0.79
Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma. Invasion Metastasis (1986) 0.78
Induction and management of diabetes mellitus in the pig. Aust J Exp Biol Med Sci (1986) 0.78
Role of CD4+ T-lymphocytes in rejection by mice of fetal pig proislet xenografts. Diabetes (1989) 0.78
Vaccinia-interleukin 2 recombinant virus or exogenous interleukin 2 does not alter the magnitude or immune response gene defects of the cytotoxic T-cell response to vaccinia virus in vivo. Scand J Immunol (1989) 0.78
The isolation and transplantation of foetal mouse proislets. Aust J Exp Biol Med Sci (1982) 0.78
Inactivated rabies vaccine produced from the Flury LEP strain of virus grown in BHK-21 suspension cells. Appl Microbiol (1973) 0.77
An analysis of tissue-specific transplantation phenomena in a minor histoincompatibility system. Transplantation (1985) 0.77
Characterisation of rat tumour cell hybrids: procoagulant and fibrinolytic activities. Aust J Exp Biol Med Sci (1985) 0.77
Studies on rat mammary adenocarcinomas: a model for metastasis. Cancer Metastasis Rev (1985) 0.77
The enhancement of human tumor necrosis factor-alpha antiviral activity in vivo by monoclonal and specific polyclonal antibodies. Lymphokine Cytokine Res (1993) 0.77
Immunogenicity of isolated foetal mouse proislets. Aust J Exp Biol Med Sci (1982) 0.77
Effect of organ culture on function of transplanted foetal pancreas. Aust J Exp Biol Med Sci (1981) 0.77
Reversal of diabetes in outbred mice by islet allotransplantation. Diabetes (1986) 0.77
The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor. Arch Virol (1995) 0.77
Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. J Immunol (1995) 0.76
Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Res Immunol (1999) 0.76
Analysis of mammary tumour cell metastasis and release of bound n-acetylneuraminic acid. Br J Cancer (1985) 0.75
Interleukin-7 enhances cell-mediated immune responses in vivo in an interleukin-2-dependent manner. Viral Immunol (1997) 0.75
A comparison of two radioimmunoassays for 7-hydroxychlorpromazine: rabbit polyclonal antibodies vs. mouse monoclonal antibodies. J Pharmacol Exp Ther (1985) 0.75
Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells. Eur J Biochem (1986) 0.75
Effects of vaccinia virus-expressed interleukin 2 on the immune system of sublethally irradiated mice. Microb Pathog (1991) 0.75
One-way cross-reaction between spinal cord protein and myelin basic protein. Prog Clin Biol Res (1984) 0.75
Increased metastatic ability and bone formation of a mammary adenocarcinoma in vivo after in vitro passaging. Eur J Cancer Clin Oncol (1984) 0.75
Cytokine regulation of mucosal responses: a rational basis for new vaccine delivery strategies. Reprod Fertil Dev (1994) 0.75
A 6-thioguanine-resistant variant of the rat mammary adenocarcinoma 13762 that is more immunogenic. Cancer Immunol Immunother (1987) 0.75
The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity. Biotechnol Ther (1994) 0.75
The reversal of diabetes by pancreatic islet transplantation. Diabetes (1982) 0.75
The in vitro culture of spleen cells from mice expressing humoral immunity leads to the development of T cells that mediate delayed-type hypersensitivity. Cell Immunol (1981) 0.75
Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor. Cancer Immunol Immunother (1985) 0.75
An inhibitor of plasminogen activator produced by tumour cell fusion hybrids. Aust J Exp Biol Med Sci (1985) 0.75
Cytokine enhancement of immune responses important for immunocontraception. Reprod Fertil Dev (1997) 0.75
One-way humoral immune cross-reactivity between bovine spinal cord protein and bovine myelin basic protein. Mol Immunol (1984) 0.75
Cellular and secreted tumor plasminogen activator: the effects of NaCl. Experientia (1986) 0.75